Gene: SPATA31C1
Official Full Name: SPATA31 subfamily C member 1provided by HGNC
Gene Summary: Predicted to be involved in cell differentiation and spermatogenesis. Predicted to be located in membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO13809 | SPATA31C1 Knockout cell line (HeLa) | Human | SPATA31C1 | 1:3~1:6 | Negative | Online Inquiry |
KO13810 | SPATA31C1 Knockout cell line (HCT 116) | Human | SPATA31C1 | 1:2~1:4 | Negative | Online Inquiry |
KO13811 | SPATA31C1 Knockout cell line (HEK293) | Human | SPATA31C1 | 1:3~1:6 | Negative | Online Inquiry |
KO13812 | SPATA31C1 Knockout cell line (A549) | Human | SPATA31C1 | 1:3~1:4 | Negative | Online Inquiry |
SPATA31C1 Gene Knockout Cell Lines are specialized cellular models engineered to have a targeted disruption of the SPATA31C1 gene, a member of the spermatogenesis-associated 31 gene family. By utilizing CRISPR-Cas9 technology, these cell lines provide researchers with a powerful tool to dissect the functional role of SPATA31C1 in various biological processes, particularly those related to male fertility and developmental biology. The knockout mechanism allows for a clear analysis of gene function through the assessment of phenotypic changes, providing insights into how the absence of SPATA31C1 influences cellular pathways and functions.
In scientific research, the importance of SPATA31C1 knockout cell lines lies in their applications for elucidating complex genetic interactions during germ cell development and their potential involvement in reproductive disorders. This can lead to significant implications in the field of andrology and reproductive medicine, paving the way for developing new therapeutic interventions and understanding male infertility. These cell lines can also be instrumental in drug discovery and screening, where the impact of pharmacological agents on the SPATA31C1 gene's pathways can be conveniently evaluated.
What sets SPATA31C1 Gene Knockout Cell Lines apart from alternative models is their specificity and accuracy in gene editing, allowing for reproducible and reliable results. Additionally, they come with full characterization and validation data, ensuring that researchers can trust their experimental outcomes. The versatility of these cell lines also means they can be adapted for various assays, including Western blotting, gene expression profiling, and functional assays, thus catering to a wide range of research needs.
Investing in SPATA31C1 Gene Knockout Cell Lines offers researchers, clinicians, and pharmaceutical developers a unique and valuable resource that enhances their capability to explore gene functions and develop solutions in reproductive health. Our company has an extensive background in providing high-quality biological products and is committed to supporting innovative research by delivering reliable tools that meet the evolving needs of the scientific community.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.